Measurement of RNAP in SSc patients is useful for the diagnosis and risk stratification of severe manifestation, such as renal crisis and severe skin sclerosis. PubMed, J Dermatol, 12/06/2014. (Also see: Antibodies in Systemic Scleroderma)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.